Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Catalytic domain of the human effector cell cycle checkpoint protein kinase materials and methods for identification of inhibitors thereof

Catalytic domain of the human effector cell cycle checkpoint protein kinase materials and methods for identification of inhibitors thereof

US Patent 6670167 · Granted Dec 30, 2003

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Cyclin dependent kinase inhibitors2025
Heteroaryl pyrrolidine and piperidine orexin receptor agonists2025
Substituted piperazine amide compounds as indoleamine 2,3-dioxygenase (IDO) inhi2025
Arylalkyl pyrazole compounds as indoleamine 2,3-dioxygenase inhibitors2024
Compositions of influenza hemagglutinin with heterologous epitopes and/or altere2024
[1.1.1] bicyclo compounds as indoleamine 2,3-dioxygenase inhibitors2022
CDK2/4/6 inhibitors2022
Cyclin dependent kinase inhibitors2022
Anti-proliferative agents for treating PAH2021
Compositions of influenza hemagglutinin with heterologous epitopes and/or altere2021
Maize event DP-004114-3 and methods for detection thereof2021
CDK2/4/6 inhibitors2020